Dr Phillip J Suffridge, MD | |
3 Medical Park Dr, Suite 300, Benton, AR 72015-3728 | |
(501) 778-1113 | |
(501) 778-5391 |
Full Name | Dr Phillip J Suffridge |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 26 Years |
Location | 3 Medical Park Dr, Benton, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730142530 | NPI | - | NPPES |
161592001 | Medicaid | AR | |
06040018300 | Other | AR | QUALCHOICE |
5N525 | Other | AR | BLUE CROSS BLUE SHIELD |
P00445226 | Other | AR | RAILROAD MEDICARE |
204462170 | Other | AR | UNITED HEALTHCARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | E2274 (Arkansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Chambers Memorial Hospital | Danville, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ophthalmology Associates Of Benton, Pllc | 3971685132 | 2 |
News Archive
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
If you've ever been told that you can't buy life insurance due to a pre-existing medical condition or that your application was rated up due to one or more medical conditions, Life Quotes, Inc. offers these tips for securing a life insurance policy at a rate you can live with.
In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.
Verde Media Group Inc. through its Biotechnology Division (VMBD) is pleased to announce that it has secured its 40,000-square-foot construction site in Asia with joint venture partner, Phoenix Energy.
› Verified 7 days ago
Entity Name | Ophthalmology Associates Of Benton, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699774794 PECOS PAC ID: 3971685132 Enrollment ID: O20080125000654 |
News Archive
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
If you've ever been told that you can't buy life insurance due to a pre-existing medical condition or that your application was rated up due to one or more medical conditions, Life Quotes, Inc. offers these tips for securing a life insurance policy at a rate you can live with.
In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.
Verde Media Group Inc. through its Biotechnology Division (VMBD) is pleased to announce that it has secured its 40,000-square-foot construction site in Asia with joint venture partner, Phoenix Energy.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Phillip J Suffridge, MD 3 Medical Park Dr Ste 300, Benton, AR 72015-3726 Ph: (501) 778-1113 | Dr Phillip J Suffridge, MD 3 Medical Park Dr, Suite 300, Benton, AR 72015-3728 Ph: (501) 778-1113 |
News Archive
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
If you've ever been told that you can't buy life insurance due to a pre-existing medical condition or that your application was rated up due to one or more medical conditions, Life Quotes, Inc. offers these tips for securing a life insurance policy at a rate you can live with.
In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.
Verde Media Group Inc. through its Biotechnology Division (VMBD) is pleased to announce that it has secured its 40,000-square-foot construction site in Asia with joint venture partner, Phoenix Energy.
› Verified 7 days ago
Dr. Annette M Enderlin, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3 Medical Park Dr, Suite 300, Benton, AR 72015 Phone: 501-778-1113 Fax: 501-778-5391 | |
Dr. Alan W Hughes, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3 Medical Park Dr, Suite 300, Benton, AR 72015 Phone: 501-778-1113 Fax: 501-778-5391 |